您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Lascufloxacin
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Lascufloxacin
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Lascufloxacin图片
CAS NO:848416-07-9
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品名称
KRP-AM1977X
产品介绍
Lascufloxacin (KRP-AM1977X) 是一种有效的口服活性的氟喹诺酮类抗菌剂。Lascufloxacin 有效抑制由多种病原体 (包括对喹诺酮类耐药的菌株) 引起的感染。Lascufloxacin 可用于多种传染病的研究,包括下呼吸道感染。
生物活性

Lascufloxacin (KRP-AM1977X) is a potent and orally active fluoroquinolone antibacterial agent. Lascufloxacin potently inhibits infections caused by various pathogens, including quinolone-resistant strains. Lascufloxacin has the potential for various infectious diseases treatment, including lower respiratory tract infections[1][2].

IC50& Target

Quinolone

 

体外研究
(In Vitro)

In the Gram-negative bacteria, Lascufloxacin shows antibacterial activities againstMoraxella catarrhalisand β-lactamase-negative ampicillin-susceptible and ampicillin-resistant strains ofHaemophilus influenzae, with an MIC90value of 0.06 μg/mL in all cases. The MIC90values againstEnterobacter spp.,Klebsiella pneumoniae, andAcinetobacter spp.are 0.25 μg/mL, 0.25 μg/mL, and 0.5 μg/mL, respectively. Lascufloxacin inhibitsE. coliandP. aeruginosawith MIC90s of 0.25 μg/mL and 4 μg/mL, respectively. The MIC50and MIC90values of Lascufloxacin againstM. pneumoniaeare 0.12 μg/mL and 0.25 μg/mL, respectively. Lascufloxacin shows potent activity against macrolide-resistantM. pneumoniaeisolates with an MIC90of 0.12 μg/mL[1].
The MICs of Lascufloxacin against parentS. aureusstrains ranged from 0.008 to 0.015 μg/mL, and those against fourth-stepparC,gyrA,parC, andgyrAmutant strains are all 2 μg/mL. Lascufloxacin shows incomplete cross-resistance against the mutant strains. The activities of Lascufloxacin against first- and second-step mutant strains ofS. pneumoniaeare more potent than the activities of other quinolones, and the MICs of Lascufloxacin againstgyrAandparCdouble mutants are 0.25 to 0.5 μg/mL[1].

体内研究
(In Vivo)

A pharmacodynamic study using a mouse thigh infection model indicates that the ratios of the free area under the curve (fAUC) to MIC in plasma required for bacteriostasis, or 1-log or 2-log CFU killing againstS. pneumoniaeisolates, are 10, 16, and 28, respectively. Lascufloxacin shows significant bacterial killing in the mouse model when emulated the area under the concentration-time curve (AUC) in plasma in dose of 75 mg per day [q.d.])[2].

分子量

439.43

Formula

C21H24F3N3O4

CAS 号

848416-07-9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.